Acorda Therapeutics, Inc. Acquisitions, Net of Cash Acquired
Acorda Therapeutics, Inc. reported Acquisitions, Net of Cash Acquired of $268.11 million for the 9-month period ending 2016-09-30, per its 10-Q filed 2017-11-07.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired · last filed 2017-11-07
- Acorda Therapeutics, Inc. payments to acquire businesses, net of cash acquired for the quarter ending 2016-09-30 was -$6.99M.
- Acorda Therapeutics, Inc. payments to acquire businesses, net of cash acquired for fiscal 2014 was $476.15M, a 6249.53% increase from fiscal 2013.
- Acorda Therapeutics, Inc. payments to acquire businesses, net of cash acquired for fiscal 2013 was $7.50M.
| Period end | Payments to Acquire Businesses, Net of Cash Acquired 3 month | Payments to Acquire Businesses, Net of Cash Acquired 6 month | Payments to Acquire Businesses, Net of Cash Acquired 9 month | Payments to Acquire Businesses, Net of Cash Acquired 12 month |
|---|---|---|---|---|
| 2016-09-30 | -$6.99M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | $268.11M 10-Q · filed 2017-11-07 | ||
| 2016-06-30 | $275.10M 10-Q · filed 2017-08-08 | |||
| 2014-12-31 | $476.15M 10-K · filed 2016-02-29 | |||
| 2013-12-31 | $7.50M 10-K · filed 2016-02-29 |